A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group
Publication in refereed journal

Times Cited
Web of Science18WOS source URL (as at 16/11/2020) Click here for the latest count
Altmetrics Information

Other information
AbstractPurpose Fenretinide is a synthetic retinoid with activity in prostate cancer and other cell lines. The aim of this study was to assess the efficacy and tolerability of fenretinide in chemotherapy-na < ve men with hormone refractory prostate cancer.
All Author(s) ListMoore MM, Stockler M, Lim R, Mok TSK, Millward M, Boyer MJ
Journal nameCancer Chemotherapy and Pharmacology
Volume Number66
Issue Number5
Pages845 - 850
LanguagesEnglish-United Kingdom
KeywordsFenretinide; Hormone refractory; Prostate cancer
Web of Science Subject CategoriesOncology; ONCOLOGY; Pharmacology & Pharmacy; PHARMACOLOGY & PHARMACY

Last updated on 2020-17-11 at 00:21